426
Participants
Start Date
December 19, 2017
Primary Completion Date
June 2, 2020
Study Completion Date
March 31, 2026
Troriluzole
Troriluzole, 140 mg capsules once daily (QD) orally for the first 4 weeks and 200 mg (140 mg+ 60 mg capsules QD) for an additional 8 weeks
Placebo
Matching capsule once daily (QD)
New York State Psychiatric Institute, New York
Richmond Behavioral Associates, Staten Island
Bio Behavioral Institute, Great Neck
Integrative Clinical Trials LLC, Brooklyn
Finger Lakes Clinical Research, Rochester
Suburban Research Associates, Media
University of Pennsylvania, Philadelphia
Pharmasite Research, Inc., Pikesville
Psychiatric Alliance of the Blue Ridge, Inc., Charlottesville
New Hope Clinical Research, Charlotte
iResearch Atlanta, LLC, Decatur
iResearch Savannah, Savannah
Clinical Neuroscience Solutions, Inc, Jacksonville
University of Florida Department of Psychiatry, Gainesville
Medical Research Group of Central Florida, Orange City
Clinical Neuroscience Solutions, Inc, Orlando
Galiz Research, Hialeah
Harmony Clinical Research, North Miami Beach
Gulfcoast Clinical Research Center, Fort Myers
SIH Research, Inc, Kissimmee
Clinical Neuroscience Solutions, Inc., Memphis
Precise Research Centers, Flowood
New Horizons Clinical Research, Cincinnati
Midwest Clinical Research Center, Dayton
Michigan Clinical Research PC, Ann Arbor
AMR-Baber Research, Inc, Naperville
Chicago Research Center, Chicago
University of Chicago Department of Psychiatry & Behavioral Neuroscience, Chicago
Phoenix Medical Research, Inc., Prairie Village
Heartland Research Associates, LLC, Wichita
Preferred Research Partners, Inc., Little Rock
InSite Clinical Research, DeSoto
FutureSearch Trials of Dallas, LP, Dallas
Baylor College of Medicine, Houston
Mountain View Clinical Research, Inc., Denver
Metropolitan Neuro Behavioral Institute, Chandler
CalNeuro Research Group, Los Angeles
Pacific Clinical Research Medical Group, Upland
Synergy Research San Diego, Lemon Grove
University of California San Diego, La Jolla
Artemis Institute for Clinical Research, San Marcos
Artemis Institute for Clinical Research, San Diego
Desert Valley Research, Rancho Mirage
Collaborative Neuroscience Network, LLC, Garden Grove
NRC Research Institute, Orange
Pacific Research Partners, LLC, Oakland
Summit Research Network (Oregon) Inc., Portland
Northwest Clinical Research Center, Bellevue
Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford
Institute of Living / Hartford Hospital, Hartford
Yale University, New Haven
Comprehensive Psychiatric Care, Norwich
McLean Hospital, Belmont
Massachusetts General Hospital, Boston
Boston Clinical Trials, Boston
ActivMed Practices and Research, Inc., Portsmouth
Center for Emotional Fitness, Cherry Hill
Lead Sponsor
Biohaven Pharmaceuticals, Inc.
INDUSTRY